Midazolam
Product Images NDC 17478-523

7 FDA label images from Akorn · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Midazolam (NDC 17478-523). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Mid05 0012 01)

Figure (Mid05 0012 01)
Chemical structure diagram of Midazolam, depicting its molecular framework including a chlorinated benzodiazepine ring and fluorophenyl group, consistent with the Midazolam active ingredient structure.*
FDA Label Image

Figure (Mid05 0012 02)

Figure (Mid05 0012 02)
Chemical structure diagram showing the equilibrium between the closed-ring form of Midazolam and its open-ring form.*
FDA Label Image

Figure (Mid05 0012 03)

Figure (Mid05 0012 03)
A line chart showing the pH dependence of the open-ring form of a compound in water. The x-axis represents pH values ranging from 2.5 to 5.5, and the y-axis shows the percentage of the open-ring form, which decreases sharply as pH increases.*
FDA Label Image

Principal Display Panel Text For Container Label (Mid05 0012 04)

Principal Display Panel Text For Container Label (Mid05 0012 04)
Midazolam Injection, USP 2 mg/2 mL (1 mg/mL) label for injection by Akorn. The label states it is for intramuscular or intravenous use only, contains benzyl alcohol, and is supplied in a 2 mL vial. Includes NDC 17478-523-02 and manufacturing details.*
FDA Label Image

Principal Display Panel Text For Carton Label (Mid05 0012 05)

Principal Display Panel Text For Carton Label (Mid05 0012 05)
Packaging label for Midazolam Injection, USP 2 mg/2 mL (1 mg/mL) by Akorn. The label indicates use for intramuscular or intravenous administration and contains 10 sterile vials of 2 mL each. It notes the presence of benzyl alcohol as a preservative, includes active and inactive ingredient details, storage instructions, and the NDC 17478-523-02.*
FDA Label Image

Principal Display Panel Text For Container Label (Mid05 0012 06)

Principal Display Panel Text For Container Label (Mid05 0012 06)
Midazolam Injection, USP label showing 50 mg/10 mL (5 mg/mL) concentration in a 10 mL vial. Labeled for intramuscular or intravenous use, contains benzyl alcohol preservative. Distributed by Akorn, includes active and inactive ingredients, storage instructions, and NDC 17478-524-10.*
FDA Label Image

Principal Display Panel Text For Carton Label (Mid05 0012 07)

Principal Display Panel Text For Carton Label (Mid05 0012 07)
Packaging label for Midazolam Injection, USP 50 mg/10 mL (5 mg/mL) by Akorn. The label indicates it is for intramuscular or intravenous use only, contains benzyl alcohol preservative, and includes 10 sterile vials of 10 mL each. Storage instructions and dosage information references are provided along with the NDC 17478-524-10.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.